Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Compass Pathways (NASDAQ:CMPS) through any online brokerage.
Other companies in Compass Pathways’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), Zura Bio Ltd (NASDAQ:ZURA), Tectonic Therapeutic Inc (NASDAQ:TECX), ARS Pharmaceuticals Inc (NASDAQ:SPRY) and CytomX Therapeutics Inc (NASDAQ:CTMX).
Compass Pathways has a consensus price target of $23.08.
The stock price for Compass Pathways (NASDAQ: CMPS) is $6.94 last updated March 11, 2026 at 7:55 PM EDT.
There are no upcoming dividends for Compass Pathways.
Compass Pathways does not have any upcoming earnings scheduled.
There is no upcoming split for Compass Pathways.
Compass Pathways is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.